Novartis Investigative Site

Westerstede/Oldenburg 26655

0 studies enrolling now · 4 studies all time

What they study most

Anti-Dyskinesia Agents, Attention Deficit/Hyperactivity Disorder, Dyskinesias, Movement Disorders, Parkinson Disease, Parkinsonian Disorders

Studies at this site

• Evaluation of the Efficacy and Safety of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias — Completed
• Open-label, Long-term Safety Extension Study of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias — Completed
• Open-label Extension Evaluating Methylphenidate Hydrochloride Extended Release in Adults With Attention Deficit/Hyperactivity Disorder — Completed
• Efficacy and Safety Study of Methylphenidate Hydrochloride Extended Release in Adults With Childhood-onset Attention Deficit/Hyperactivity Disorder (ADHD) — Completed